MIRA Pharmaceuticals, Inc. (MIRA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 1.1M | 5.82M | 1.32M | 1.55M | 1.81M | 2.44M | 2.08M | 1.73M | 1.77M | 3.06M | 3.16M | 970.22K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 578.7K | 5.33M | 904.35K | 1.05M | 1.49M | 1.58M | 1.01M | 1.12M | 1.01M | 2.67M | 2.14M | 1.07M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 524.78K | 496.54K | 412.64K | 496.2K | 314.4K | 861.44K | 1.07M | 614.46K | 762.28K | 387.12K | 1.02M | -101.02K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.1M | -5.82M | -1.32M | -1.55M | -1.81M | -2.44M | -2.08M | -1.73M | -1.77M | -3.06M | -3.16M | -970.22K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 38.87% | -138.94% | 36.73% | 10.67% | -2.09% | 20.24% | 34.13% | -78.38% | -32.01% | -126.78% | - | - |
| EBITDA | -1.1M | -5.82M | -1.32M | -1.55M | -1.81M | -2.44M | 0 | -1.73M | -1.77M | 0 | 0 | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 38.87% | -138.94% | - | 10.67% | -2.09% | - | - | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 2.08M | 0 | 0 | 3.06M | 3.16M | 970.22K |
| EBIT | -1.1M | -5.82M | -1.32M | -1.55M | -1.81M | -2.44M | -2.08M | -1.73M | -1.77M | -3.06M | -3.16M | -970.22K |
| Net Interest Income | 44.91K | 53.3K | 15.7K | 8.49K | 21.42K | 38.1K | 37.75K | 39.4K | 50.42K | -2.73M | -427.73K | -295.89K |
| Interest Income | 44.91K | 53.3K | 15.7K | 8.49K | 21.42K | 38.1K | 37.75K | 39.4K | 50.42K | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.73M | 427.73K | 295.89K |
| Other Income/Expense | -46.67K | -158.49K | 179.31K | 8.39K | 21.42K | 38.1K | 37.75K | 39.4K | 50.42K | -2.73M | -427.73K | -295.89K |
| Pretax Income | -1.15M | -5.98M | -1.14M | -1.54M | -1.78M | -2.4M | -2.04M | -1.69M | -1.72M | -5.79M | -3.59M | -1.27M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.15M | -5.98M | -1.14M | -1.54M | -1.78M | -2.4M | -2.04M | -1.69M | -1.72M | -5.79M | -3.59M | -1.27M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 35.52% | -149.34% | 44.34% | 9.08% | -3.84% | 58.54% | 43.03% | -33.58% | -28.09% | -328.86% | - | - |
| Net Income (Continuing) | -1.15M | -5.98M | -1.14M | -1.54M | -1.78M | -2.4M | -2.04M | -1.69M | -1.72M | -5.79M | -3.59M | -1.27M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.03 | -0.14 | -1.18 | -0.09 | -0.11 | -0.16 | -0.14 | -0.11 | -0.09 | -0.39 | -0.24 | -0.09 |
| EPS Growth % | 72.73% | 12.5% | -742.86% | 17.73% | -26.15% | 58.97% | 41.67% | -28.35% | 4.07% | -326.23% | - | - |
| EPS (Basic) | -0.03 | -0.14 | -1.18 | -0.09 | -0.11 | -0.16 | -0.14 | -0.11 | -0.09 | -0.39 | -0.24 | -0.09 |
| Diluted Shares Outstanding | 41.94M | 23.69M | 19.27M | 16.99M | 16.65M | 15.44M | 15.07M | 14.78M | 19.71M | 14.78M | 14.78M | 14.78M |
| Basic Shares Outstanding | 41.94M | 23.69M | 19.27M | 16.99M | 16.65M | 15.44M | 15.07M | 14.78M | 19.71M | 14.78M | 14.78M | 14.78M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |